Experts and patients alike perspectives on the ABI, or auditory brainstem implant, considered by many to be a miracle hearing device for people with profound hearing loss who cannot benefit from hearing aids or cochlear implants.
Cochlear released the small bone conduction Baha 5 Sound Processor for people who are deaf in one ear, or have conductive or mixed hearing loss. Users can stream sound and control the processor from the iPhone, iPad, or iPod touch.
Medical device giant Medtronic has purchased bone-anchored hearing implant manufacturer Sophono. Medtronic is the world's third largest medical device manufacturer with a market capitalization of over $100 billion and the company employs 85,000 people, including 5,800 scientists and engineers, in 160 countries.
The first US patient has received MED-EL's Synchrony cochlear implant, which was FDA-approved in January 2015 for use in MRI without magnet removal.
Cochlear implant manufacturer Nurotron Biotechnology has announced that it is expanding its organization ten-fold in 2015 with new facilities and additional staff in China.
Advanced Bionics' HiRes 90K and HiRes 90K Advantage cochlear implants received CE Mark approval to undergo 1.5T MRI scans without removing the internal magnet.
MED-EL has received FDA approval for its new Synchrony cochlear implant (CI), which can be used for MRI without magnet removal.
The NAE announced that MED-EL co-founders Ingeborg and Erwin Hochmair, as well as cochlear implant pioneers Blake Wilson, Graeme Clark, and Michael Merzenich, have been awarded the 2015 Russ Prize for bioengineering.
MED-EL USA announced the FDA approval of the WaterWear waterproof cover for RONDO, the company's cochlear implant single-unit audio processor.
The Center for Medicare and Medicaid Services (CMS) has released its final rule, stating that it will maintain Medicare coverage of auditory osseointegrated implants (AOIs), reversing its earlier proposal to have AOIs classified as hearing aids (thereby eliminating coverage for them).
The ACI Alliance has published the Proceedings of the organization's First Annual Symposium which is now available online.
New University of Missouri study reinforces the importance of early hearing interventions for infants, and indicates that infants with profound hearing loss who received cochlear implants reached the vocalization levels of their hearing peers—putting them back on track for language development.
The 3-day Symposium reportedly brings together more than 900 clinicians, scientists, educators, government officials, and health insurance representatives for educational and networking opportunities, as well as interaction with vanguard companies on the cutting edge of technology in hearing implants.
The promotion from MED-EL is designed to allow patients to move forward with confidence, knowing that they can access the latest in sound processing strategies with a new audio processor as soon as it becomes available in the United States.
Bone-anchored device manufacturer Sophono Inc has entered into a global partnership with China-based Hangzhou Nurotron Biotechnology Co Ltd, a manufacturer of the cochlear implant systems and BTE cochlear speech processors. A jointly-owned company, SophonoTron™, has been created to manage several of the commercial activities for the two partners.
The Centers for Medicare and Medicaid Services (CMS) proposed a new rule on July 11 that would effectively end coverage for people who need bone anchored hearing solutions. The deadline for clinicians and their patients to submit comments ends September 2.
A three-year-old is the first child in the United States to undergo an auditory brainstem implant surgery in an FDA-approved trial supported by a National Institutes of Health clinical trial grant.
Results suggest that 6-month-old infants need less distortion and more frequency information than older children and adults to discriminate speech.
A new study from Indiana University shows that children with profound deafness who receive a cochlear implant had as much as 5 times the risk of delays in areas of working memory, controlled attention, planning, and conceptual learning as children with normal hearing. The research also shows that many children develop average or better executive functioning skills after cochlear implantation. Once again, age of implantation may be a key.
Researchers have for the first time developed a way of using electrical pulses delivered from a cochlear implant to generate neurotrophins which can help regenerate auditory nerve endings. Ultimately, the therapy could allow CI users to enjoy a broader dynamic and tonal range, and it also has implications for other devices used in deep brain stimulation.